Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.

Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, Leon MB, Dangas GD.

Am J Cardiol. 2004 Aug 1;94(3):300-5.

PMID:
15276092
2.

Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.

Roy P, Raya V, Okabe T, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.

Am J Cardiol. 2008 Jun 1;101(11):1544-9. doi: 10.1016/j.amjcard.2008.02.035. Epub 2008 Apr 18.

PMID:
18489931
3.

Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.

PMID:
22566286
4.

The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary intervention.

Papafaklis MI, Naka KK, Papamichael ND, Kolios G, Sioros L, Sclerou V, Katsouras CS, Michalis LK.

Catheter Cardiovasc Interv. 2007 Feb 1;69(2):189-97.

PMID:
17253600
5.

Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.

Kowalczyk J, Lenarczyk R, Kowalski O, Swiatkowski A, StabryƂa-Deska J, Kurek T, Honisz G, Kukulski T, Gasior M, Kalarus Z.

Kardiol Pol. 2007 Jun;65(6):635-43; discussion 644.

6.

Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.

Ota T, Umeda H, Yokota S, Miyata S, Takamura A, Sugino S, Hayashi K, Ishiki R, Takeichi Y, Iwase M, Inagaki H, Murohara T.

Am Heart J. 2009 Jul;158(1):92-8. doi: 10.1016/j.ahj.2009.04.013.

PMID:
19540397
7.
8.

Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.

Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, Mintz GS, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB.

J Invasive Cardiol. 2003 Jan;15(1):18-22.

PMID:
12499523
9.

Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.

Ashrith G, Lee VV, Elayda MA, Reul RM, Wilson JM.

Am J Cardiol. 2010 Aug 1;106(3):348-53. doi: 10.1016/j.amjcard.2010.03.037. Epub 2010 Jun 18.

PMID:
20643244
10.

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency.

Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB.

J Am Coll Cardiol. 2000 Nov 1;36(5):1542-8.

12.

Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.

Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H.

J Invasive Cardiol. 2006 Dec;18(12):577-83.

PMID:
17197706
13.

Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients.

Hassani SE, Chu WW, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Weissman NJ, Waksman R.

J Invasive Cardiol. 2006 Jun;18(6):273-7.

PMID:
16751681
14.

Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.

Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R.

Am J Cardiol. 2005 Jan 1;95(1):13-9.

PMID:
15619387
15.

Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary intervention.

Kowalczyk J, Lenarczyk R, Kowalski O, Sredniawa B, Musialik-Lydka A, Gasior M, Polonski L, Zembala M, Gumprecht J, Kalarus Z.

J Interv Cardiol. 2007 Apr;20(2):143-52.

PMID:
17391223
16.

Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure.

Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, Satler LF, Lansky AJ, Stone GW, Leon MB.

Catheter Cardiovasc Interv. 2002 Jan;55(1):66-72.

PMID:
11793497
17.

Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).

Ix JH, Mercado N, Shlipak MG, Lemos PA, Boersma E, Lindeboom W, O'Neill WW, Wijns W, Serruys PW.

Am Heart J. 2005 Mar;149(3):512-9.

PMID:
15864241
18.

Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes.

Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA.

Am J Cardiol. 2003 Sep 1;92(5):509-14.

PMID:
12943868
19.

[Long-term prognosis after coronary revascularization in patients with end-stage renal disease on dialysis: comparison of percutaneous coronary intervention and coronary artery bypass grafting].

Fujimoto Y, Ishiwata S, Dohi T, Masuda J, Fujimoto H, Mitani H, Maehara A, Ohno M, Yamaguchi T, Tanaka K, Naruse Y.

J Cardiol. 2007 Jul;50(1):11-20. Japanese.

PMID:
17685025
20.

Survival after coronary revascularization among patients with kidney disease.

Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA; Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators.

Circulation. 2004 Oct 5;110(14):1890-5. Epub 2004 Sep 27. Review.

Supplemental Content

Support Center